Delivery Order SPE2DB22D1103-SPE2DB24FTMG3
Award Date
6/17/24
Potential Completion Date
6/18/24
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a firm-fixed-price delivery order contract valued at $1,210.55 to AmerisourceBergen Drug Corp for the supply of 4,566,110,813 units of the prescription drug Vyvanse 40 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that the DLA Troop Support Medical has with AmerisourceBergen, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,799.28 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,763,686 units of Vyvanse 30 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support...
The U.S. Defense Logistics Agency (DLA) awarded a $1,681.65 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,377,092 Vyvanse 40 mg capsules in 100-count bottles. This order falls under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical supplies to...
The U.S. Defense Logistics Agency (DLA) awarded a $1,072.00 fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,556 units of Vyvanse 30 mg capsules. This contract has an ultimate completion date of August 22, 2024 and is not associated with any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,196,506 units of Vyvanse 40 mg capsules. The $2,240.98 contract has an ultimate completion date of April 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,555,283 units of Vyvanse 30 mg capsules. The contract has a potential value of $4,074.18 and a completion date of February 6, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $10,838.56 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,734,299 units of the prescription medication Vyvanse (60mg capsules) over a period ending on May 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, serving as the primary vehicle for the company to...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide 4,565,128,796 units of the prescription drug Vyvanse 20 mg capsules. The $6,573.70 firm-fixed-price contract has a completion date of July 12, 2024 and was not set aside for any specific business category. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency (DLA) has awarded a $9,524.76 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of 4,565,333,941 units of the prescription drug Vyvanse 40 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of medical...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $10,833.45 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,559,778,029 units of Vyvanse 30 mg capsules. The contract has a firm fixed price and an ultimate completion date of January 31, 2023. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026, which...